Using Long-Acting Injectable Antipsychotics to Enhance the Potential for Recovery in Schizophrenia
Clicks: 256
ID: 268032
2020
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
65.7
/100
256 views
205 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Abstract The goals of schizophrenia treatment are to control symptoms, prevent relapse, and improve functioning and quality of life. For many patients, these goals are not being met. This report highlights information provided by experts on the reasons for, impact of, and means to reduce relapse in patients with schizophrenia; on patient-centered and patient-reported assessment; [ā¦]| Reference Key |
correll2020theusing
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Christoph U. Correll;John Lauriello; |
| Journal | the journal of clinical psychiatry |
| Year | 2020 |
| DOI | DOI not found |
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.